MainboardGMP
LIVE
LIVE GMP
MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·
Home › IPOs › Ami Organics Ltd.
AM
Ami Organics Ltd.
CLOSED NSE & BSE Bookbuilding IPO Fresh Capital-cum-Offer for Sale Ami Organics IPO GMP
GREY MARKET PREMIUM
₹ 0
No premium data
EST. LISTING PRICE
₹610
Issue Price: ₹ 610
Issue Price
₹610
Face Value
₹10
Lot Size
24 shares
Open Date
01 Sep 2021
Close Date
03 Sep 2021
Allotment
08 Sep 2021
Listing Date
14 Sep 2021
Exchange
NSE & BSE
Ami Organics IPO About the Company

Incorporated in 2004, Ami Organics Limited is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals.

The company has developed over 450 pharma intermediates across 17 key therapeutic areas i.e. anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It supplies its products to more than 150 customers (including international customers) directly in India and in 25 countries overseas i.e. Europe, USA, China, Israel, Japan, Latin America, etc. Laurus Labs, Cadila Healthcare, Cipla Ltd are some of the domestic customers whereas Organike s.r.l.a. Socio Unico, Fermion Oly, Medichem S.A. and Midas Pharma GmbH are some of the international customers.

The company has three manufacturing facilities in Gujarat situated at Sachin, Ankleshwar & Jhagadia, with an aggregate installed capacity of 6,060 MTPA.

Competitive strengths:

  • One of the leading manufacturers of certain Pharma Intermediates i.e. Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban.
  • Strong and diversified product portfolio with 450+ Pharma Intermediates across 17 therapeutic areas.
  • Extensive geographical presence and diversified customer base.
  • Strong R&D, sales and marketing capabilities
  • Consistent financial performance track record.
...read more
Ami Organics IPO Objects of the Issue
Purpose Amount (₹ Cr)
1 Repayment/prepayment of certain financial facilities availed by the Company ₹140
2 Funding working capital requirements of the Company; and ₹90
3 General corporate purposes ₹46
Ami Organics IPO Lead Managers
Ambit Pvt.Ltd. Axis Capital Ltd. Intensive Fiscal Services Pvt.Ltd.
Financial Summary Amount in Crore
Metric 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 413 232 213
Revenue 342 242 239
PAT 54 27 23
Issue Details
Total Shares Offered
9,338,288 (100%)
Pre-Issue Shareholding
33,158,374 shares
Post-Issue Shareholding
36,437,063 shares
UPI Mandate
03 Sep 2021
IPO Analytics Dashboard
LIVE
Ami Organics IPO GMP Insights
👤
Retail Demand
Good
💼
HNI Interest
Good
🏦
QIB Demand
Strong
📊
Valuation
Moderate
Ami Organics IPO GMP Strength Score
7 / 10 Good
0–3 Weak 3–6 Moderate 6–8 Good 8–10 Strong
Ami Organics IPO Category-wise Subscription Shares offered, bid & amount
Category Sub (x) Offered Bid For
🏦 QIB — 4,669,143 (50%) —
💼 NII / HNI — 1,400,744 (15%) —
👤 Retail (RII) — 3,268,401 (35%) —
Σ Total — 9,338,288 (100%) —

* Amount calculated at upper price band (₹610) ·  ** Total includes all investor categories

Subscription Overview Share allocation by investor category
🏦
QIB ? 4,669,143 (50%)
50%
💼
NII / HNI ? 1,400,744 (15%)
15%
👤
Retail (RII) ? 3,268,401 (35%)
35%
Total Shares Offered 9,338,288 (100%)
Ami Organics IPO Application Sizing Minimum investment by category
👤 Retail Investors ?
Min. Lots 1
Shares / Lot 24
Min. Investment ₹14,640
💼 HNI Investors ?
Min. Lots 14
Min. Shares 336
Min. Investment ₹204,960
🏛️ bHNI (>₹10L) ?
Min. Lots 69
Min. Shares 1,656
Min. Investment ₹1,010,160
Ami Organics IPO Timeline & Key Dates
  1. 1 💳 Initiation of Refund 09 Sep 2021
  2. 2 📂 Credit of Shares to Demat 13 Sep 2021
  3. 3 🔒 Lock-in Period (30%) October 8, 2021
  4. 4 🔒 Lock-in Period (50%) December 7, 2021
Investor Interpretation
  • Retail allocation is good at 35% of the total offering.
  • HNI/NII demand is good at 15%.
  • Institutional (QIB) interest is strong at 50%.

This IPO shows moderate investor interest. Review financial details and compare valuation with industry peers before investing.

STOCK PRICE HISTORY  ·  NSE
—
Issue Price: ₹ 610  ·  Symbol: —
H —
L —
O —
Ami Organics IPO Company Info
📍 Plot No. 440/4, 5 & 6, Road No. 82/A GIDC Sachin, Surat – 394 230 Sachin, Gujarat
Visit Website
Ami Organics IPO Registrar
MUFG Intime India Pvt.Ltd.
Check Allotment Status
Ami Organics IPO FAQs
Ami Organics IPO has already listed. Its last recorded GMP was ₹0. GMP is only indicative and never a guarantee of listing gains.
The issue price of Ami Organics IPO is ₹610 per share. One lot has 24 shares, so the minimum investment is about ₹14,640. It is a Fresh Capital-cum-Offer for Sale issue.
Ami Organics IPO opened on 01 Sep 2021 and closed on 03 Sep 2021. Allotment is tentatively finalised on 08 Sep 2021. Shares are listed on NSE & BSE on 14 Sep 2021.
Incorporated in 2004, Ami Organics Limited is one of the leading research and development driven manufacturers of specialty chemicals.
As per the offer document, Ami Organics plans to use the IPO proceeds for: 1 Repayment/prepayment of certain financial facilities availed by the Company (₹140); 2 Funding working capital requirements of the Company; and (₹90); 3 General corporate purposes (₹46).
The lead managers of Ami Organics IPO are Ambit Pvt.Ltd., Axis Capital Ltd., Intensive Fiscal Services Pvt.Ltd..
Ami Organics IPO is proposed to list on NSE & BSE; it is a Bookbuilding IPO and the issue is a Fresh Capital-cum-Offer for Sale.
Disclaimer

The information on mainboardgmp.com is provided for educational and informational purposes only.

We are not a Securities and Exchange Board of India (SEBI)-registered investment advisor, analyst, broker, or financial planner. The content, data, and insights on this website, including Grey Market Premium (GMP), subscription data, IPO dates, and market information, are not intended as financial advice or recommendations to buy, sell, or hold securities.

GMP and related IPO data are collected from unofficial market sources and may not reflect actual IPO listing performance or future price movements. You should not rely solely on the information provided here to make financial or investment decisions.

Investing in IPOs and securities involves risk. Always conduct your own research and consult a qualified SEBI-registered financial advisor before making investment decisions. mainboardgmp.com and its owners shall not be liable for any financial losses, trading losses, or damages arising from use of this website.

By using this website, you acknowledge and agree that you use the content at your own risk.